ALBANY MOLECULAR RESEARCH, INC. COMPLETES STRATEGIC EUROPEAN ACQUISITION
Albany Molecular Research, Inc. has successfully completed the acquisition of
ComGenex, located in Budapest, Hungary. On January 30, AMRI announced the signing
of a stock purchase agreement to acquire ComGenex, a privately held drug discovery
services company that combines chemical synthesis and computational chemistry
to create drug-like compounds.
Genetic Engineering News